Acute and long-term treatment outcome in depressed inpatients with vs. without anxious features: Results of a one-year follow-up study

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 1055-1061

  Köhler, Stephan ^a   Unger, Theresa ^b   Hoffmann, Sabine ^c   Steinacher, Bruno ^d   Fydrich, Thomas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Kliniken im Theodor Wenzel Werk   (Germany)

^d Vivantes Wenckebach Klinikum   (Germany)

Author keywords

Acute treatment; Anxiety; Anxious depression; Depression; Follow up; Treatment outcome

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ANXIOUS DEPRESSION; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL FEATURE; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; EXTERNAL VALIDITY; FEMALE; FOLLOW UP; GROUP THERAPY; HAMILTON SCALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MOVEMENT THERAPY; MUSCLE RELAXATION TRAINING; MUSIC THERAPY; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; RELAPSE; RELAXATION TRAINING; REMISSION; RISK REDUCTION; SOMATOFORM DISORDER; SPORT; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE TREATMENT; ANXIETY; ANXIOUS DEPRESSION; DEPRESSION; FOLLOW-UP; TREATMENT OUTCOME;

ADULT; AGED; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INPATIENTS; LONG-TERM CARE; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PREVALENCE; RECURRENCE; TREATMENT OUTCOME;

EID: 84889089929     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.05.043     Document Type: Article

References (28)

1. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., 1961. An inventory for measuring depression. Archives of General Psychiatry 4, 561-571.
2. C1PS, 2005. [1nternational Scales for Psychiatry]. Gottingen: Beltz Test GmbH.
3. Cleary, P., Guy, W., 1977. Factor analysis of the Hamilton depression scale. Drugs Under Experimental and Clinical Research 1, 115-120.
4. Davidson, J.R., Meoni, P., Haudiquet, V., Cantillon, M., Hackett, D., 2002. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress Anxiety 16, 4-13.
5. Davis, L.L., Frazier, E., Husain, M.M., Warden, D., Trivedi, M., Fava, M., Cassano, P., McGrath, P.J., Balasubramani, G.K., Wisniewski, S.R., Rush, A.J., 2006. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR.*D cohort. American Journal on Addictions 15, 278-285.
6. Derogatis, L.R., Melisaratos, N., 1983. The Brief Symptom 1nventory: an introductory report. Psychological Medicine 13, 595-605.
7. Endicott, J., Spitzer, R.L., Fleiss, J.L., Cohen, J., 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766-771.
8. Fava, M., Alpert, J.E., Carmin, C.N., Wisniewski, S.R., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., Morgan, D., Schwartz, T., Balasubramani, G.K., Rush, A.J., 2004. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR.*D. Psychological Medicine 34, 1299-1308.
9. Fava, M., Rush, A.J., Alpert, J.E., Balasubramani, G.K., Wisniewski, S.R., Carmin, C.N., Biggs, M.M., Zisook, S., Leuchter, A., Howland, R., Warden, D., Trivedi, M.H., 2008. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR.*D report. American Journal of Psychiatry 165, 342-351.
10. Fava, M., Rush, A.J., Alpert, J.E., Carmin, C.N., Balasubramani, G.K., Wisniewski, S.R., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., 2006. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Canadian Journal of Psychiatry 51, 823-835.
11. Fawcett, J., Barkin, R.L., 1998. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. Journal of Clinical Psychiatry 59, 123-127.
12. Frank, E., Prien, R.F., Jarrett, R.B., Keller, M.B., Kupfer, D.J., Lavori, P.W., Rush, A.J., Weissman, M.M., 1991. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851-855.
13. Guy, W., 1976. Clinical Global Impressions (CG1). ECDEU Assessment Manual for Psychopharmacology US Department of Health, Education, and Welfare Publication (ADM) 76-338. MD: National 1nstitute of Mental Health, Rockville, pp. 218-222.
14. Hamilton, M., 1960. A rating scale for depression. Journal of Neurology, Neurosur-gery & Psychiatry 23, 56-62.
15. Harter, M., Klesse, C., Bermejo, I., Schneider, F., Berger, M., 2010. Unipolar depression: diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline. Deutsches Arzteblatt international 107, 700-708.
16. Hiller, W., Zaudig, M., Mombour, W., 2005. 1DCL: 1CD-10 Checklists Hogrefe, Gottingen.
17. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., 2003. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 289, 3095-3105.
18. Levine, J., Cole, D.P., Chengappa, K.N., Gershon, S., 2001. Anxiety disorders and major depression, together or apart. Depress Anxiety 14, 94-104.
19. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T., Murray, C.J., 2006. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747-1757.
20. Melartin, T.K., Rytsala, H.J., Leskela, U.S., Lestela-Mielonen, P.S., Sokero, T.P., 1sometsa, E.T., 2002. Current comorbidity of psychiatric disorders among DSM-1V major depressive disorder patients in psychiatric care in the Vantaa Depression Study. Journal of Clinical Psychiatry 63, 126-134.
21. Nelson, J.C., 2010. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depress Anxiety 27, 12-18.
22. Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Stewart, J.W., Warden, D., Niederehe, G., Thase, M.E., Lavori, P.W., Lebowitz, B.D., McGrath, P.J., Rosenbaum, J.F., Sackeim, H.A., Kupfer, D.J., Luther, J., Fava, M., 2006.Acuteandlonger-termoutcomes in depressed outpatients requiring one or several treatment steps: a STAR.*D report. American Journal of Psychiatry 163, 1905-1917.
23. Rush, A.J., Zimmerman, M., Wisniewski, S.R., Fava, M., Hollon, S.D., Warden, D., Biggs, M.M., Shores-Wilson, K., Shelton, R.C., Luther, J.F., Thomas, B., Trivedi, M.H., 2005. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. Journal of Affective Disorders 87, 43-55.
24. Tollefson, G.D., Holman, S.L., Sayler, M.E., Potvin, J.H., 1994. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. Journal of Clinical Psychiatry 55, 50-59.
25. Trivedi, M.H., Daly, E.J., 2008. Treatment strategies to improve and sustain remission in major depressive disorder. Dialogues in Clinical Neuroscience 10, 377-384.
26. Unger, T., Hoffmann, S., Kohler, S., Mackert, A., Fydrich, T., 2012. Personality disorders and outcome of inpatient treatment for depression: a 1-year prospective follow-up study. Journal of Personality Disorders.
27. Wiethoff, K., Bauer, M., Baghai, T.C., Moller, H.J., Fisher, R., Hollinde, D., Kiermeir, J., Hauth, 1., Laux, G., Cordes, J., Brieger, P., Kronmuller, K.T., Zeiler, J., Adli, M., 2010. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. Journal of Clinical Psychiatry 71, 1047-1054.
28. Zimmerman, M., Chelminski, 1., McDermut, W., 2002. Major depressive disorder and axis 1 diagnostic comorbidity. Journal of Clinical Psychiatry 63, 187-193.